Association of Lymph Node Sampling and Clinical Volume in Lobectomy for Non-Small Cell Lung Cancer

被引:5
|
作者
Udelsman, Brooks, V
Chang, David C.
Boffa, Daniel J.
Gaissert, Henning A.
机构
[1] Yale Sch Med, Div Thorac Surg, New Haven, CT USA
[2] Massachusetts Gen Hosp, Codman Ctr Clin Effectiveness, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Div Thorac Surg, Boston, MA 02114 USA
来源
ANNALS OF THORACIC SURGERY | 2023年 / 115卷 / 01期
关键词
THORACOSCOPIC LOBECTOMY; HOSPITAL VOLUME; SURVIVAL; OUTCOMES; RESECTION; SOCIETY; NUMBER;
D O I
10.1016/j.athoracsur.2022.05.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Sampling of >= 10 lymph nodes during lobectomy for non-small cell lung cancer (NSCLC) was a previous surveillance metric and potential quality metric of the American College of Surgeons Commission on Cancer. We sought to determine guideline adherence and its relationship to hospital lobectomy volume within The Society of Thoracic Surgeons General Thoracic Surgery Database. METHODS Participant centers providing elective lobectomy for NSCLC within The Society of Thoracic Surgeons General Thoracic Surgery Database (2012-2019) were divided into tertiles according to annual volume. Average hospital nodal harvest of >= 10 nodes per lobectomy defined the primary outcome. Univariable analysis compared average patient and operative characteristics between the participant centers. Multivariable logistic regression was used to determine independent factors associated with average clinical center nodal harvest of >= 10 nodes.RESULTS Median annual lobectomy volume was 6.2, 19.9, and 42.7 for low-, medium-, and high-volume participant centers. Among 305 centers and 43597 patients, 5.6% of lobectomies occurred in low-volume centers, 24.0% in medium-volume centers, and 70.4% in high-volume centers. Average rates of >= 10 nodes per lobectomy were excised in 44.0% of low-volume centers, 70.6% of medium-volume centers, and 75.2% of high-volume centers (P < .001). On multivariable analysis, average nodal excision of >= 10 nodes was strongly associated with medium-volume (odds ratio, 2.94; CI, 1.57-5.50, P < .01) and high-volume (odds ratio, 3.82; CI, 1.95-7.46; P < .001) participant centers.CONCLUSIONS Although higher center volume and increased nodal harvest are associated, 25% of high-volume centers average a rate of <10 lymph nodes per lobectomy for NSCLC. Low nodal yield may underestimate stage, with implications for adjuvant therapy and long-term survival. (Ann Thorac Surg 2023;115:166-74) (c) 2023 by The Society of Thoracic Surgeons
引用
收藏
页码:166 / 173
页数:8
相关论文
共 50 条
  • [1] Lymph node assessment in early stage non-small cell lung cancer lymph node dissection or sampling?
    Gail E. Darling
    [J]. General Thoracic and Cardiovascular Surgery, 2020, 68 : 716 - 724
  • [2] Lymph node assessment in early stage non-small cell lung cancer lymph node dissection or sampling?
    Darling, Gail E.
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (07) : 716 - 724
  • [3] The association of robotic lobectomy volume and nodal upstaging in non-small cell lung cancer
    Okusanya, Olugbenga T.
    Lutfi, Waseem
    Baker, Nicholas
    Dhupar, Rajeev
    Christie, Neil A.
    Levy, Ryan M.
    Martinez-Meehan, Deirdre
    Siripong, Nalyn
    Luketich, James D.
    Sarkaria, Inderpal S.
    [J]. JOURNAL OF ROBOTIC SURGERY, 2020, 14 (05) : 709 - 715
  • [4] The association of robotic lobectomy volume and nodal upstaging in non-small cell lung cancer
    Olugbenga T. Okusanya
    Waseem Lutfi
    Nicholas Baker
    Rajeev Dhupar
    Neil A. Christie
    Ryan M. Levy
    Deirdre Martinez-Meehan
    Nalyn Siripong
    James D. Luketich
    Inderpal S. Sarkaria
    [J]. Journal of Robotic Surgery, 2020, 14 : 709 - 715
  • [5] eComment: Lymph node dissection or sampling in patients with non-small cell lung cancer?
    Nosotti, Mario
    Palleschi, Alessandro
    De Simone, Matilde
    Cioffi, Ugo
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 13 (03) : 315 - 315
  • [6] Clinical Implication of Occult Lymph Node Metastasis in the Remaining Lobes After Lobectomy in Non-small Cell Lung Cancer
    Hyun, K.
    Park, S.
    Lee, H. J.
    Park, I. K.
    Kang, C. H.
    Kim, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2353 - S2353
  • [7] Thoracoscopic lobectomy with systemic lymph node for dissection for lymph node positive non-small cell lung cancer - Is thoracoscopic lymph node dissection feasible?
    Shiraishi, T.
    Hiratsuka, M.
    Yoshinaga, Y.
    Yamamoto, S.
    Iwasaki, A.
    Shirakusa, T.
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2008, 56 (03): : 162 - 166
  • [8] Lymph node micrometastasis in non-small cell lung cancer
    Sun, Jiajing
    Wu, Sikai
    Jin, Zixian
    Ren, Sijia
    Cho, William C.
    Zhu, Chengchu
    Shen, Jianfei
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [9] Wedge Resection vs Lobectomy for Clinical Stage IA Non-Small Cell Lung Cancer With Occult Lymph Node Disease
    Kneuertz, Peter J.
    Abdel-Rasoul, Mahmoud
    D'Souza, Desmond M.
    Moffatt-Bruce, Susan D.
    Merritt, Robert E.
    [J]. ANNALS OF THORACIC SURGERY, 2023, 115 (06): : 1344 - 1351
  • [10] Required area of lymph node sampling during segmentectomy for clinical stage IA non-small cell lung cancer
    Nomori, Hiroaki
    Ohba, Yasuomi
    Shibata, Hidekatsu
    Shiraishi, Kenji
    Mori, Takeshi
    Shiraishi, Shinya
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 139 (01): : 38 - 42